Tevogen Bio Holdings (TVGN) Current Leases (2023 - 2026)
Tevogen Bio Holdings (TVGN) reported Current Leases of $327740.0 for Q1 2026, up 91.83% on a YoY basis from $170851.0 in Q1 2025, and little changed quarter-over-quarter from $327740.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Current Leases (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Current Leases for 4 years, with the latest figure at $327740.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 91.83% year-over-year to $327740.0; the trailing twelve-month figure through Mar 2026 stood at $327740.0 (up 91.83% YoY), and the FY2025 full-year result was $327740.0, up 43.08% from the prior year.
- Current Leases for Q1 2026 stood at $327740.0, roughly flat from $327740.0 in the prior quarter.
- The five-year high for Current Leases was $327740.0 in Q2 2025, with the low at $170851.0 in Q1 2025.
- Historically, Current Leases has averaged $275135.0 across 4 years, with a median of $264627.5 in 2024.
- Annual changes were most pronounced in 2025 — Current Leases plunged 34.44% — and 2026, when it jumped 91.83%.
- Tevogen Bio Holdings' Current Leases stood at $252714.0 in 2023, then slipped by 9.36% to $229063.0 in 2024, then surged by 43.08% to $327740.0 in 2025, then changed by 0.0% to $327740.0 in 2026.
- The last three Current Leases figures came in at $327740.0 (Q1 2026), $327740.0 (Q4 2025), and $327740.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | 327,740.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 327,740.00 |
| Dec 31, 2025 | 327,740.00 |
| Sep 30, 2025 | 327,740.00 |
| Jun 30, 2025 | 327,740.00 |
| Mar 31, 2025 | 170,851.00 |
| Dec 31, 2024 | 229,063.00 |
| Sep 30, 2024 | 258,507.00 |
| Jun 30, 2024 | 268,672.00 |
| Mar 31, 2024 | 260,583.00 |
| Dec 31, 2023 | 252,714.00 |